BioPharm International - Articles on bioprocessing methods, regulatory compliance, and biotech strategies
ASBPE
Latest Issue
Our Past Issues>>

ADVERTISEMENT

Online Exclusive

What Can Biotech Learn From Toyota's Recalls?
FindPharma
Featured Jobs

More Jobs

Author Guidelines
Previous StoryPlay / Pause Next Story
Podcast: USP's Tina Morris on New Bio Chapters
Podcast: Gillian Woollett on the Future of Biologics
Podcast: Regulus Therapeutics and microRNA Drug Delivery
Podcast: USP's Matthew van Hook on Biosimilars
Podcast Interview with NIH Director Francis S. Collins

From the Editor
Here's to a Year of Compromise

Compliance Notes
Auditing by the Numbers

Perspectives on Outsourcing
Contract Services in 2012

Burrill on Biotech
Global Economic Woes Overshadow Biotech Industry Advances in 2011

Final Word
USAID Moves Global Healthcare Initiatives Forward

FDA approves Inlyta to treat patients with a type of advanced kidney cancer
Department of Justice files Consent Decree of Permanent injunction against Ranbaxy
Maine company holds cold smoked salmon product after FDA order
FDA permits marketing of first test for risk of rare brain infection in some people treated with Tysabri
FDA approves Voraxaze to treat patients with toxic methotrexate levels

Global Market Boom for Generic Drugs
January 24, 2012
AstraZeneca and IMS Health Announce Data and Research Collaboration
January 24, 2012
FDA Recommends Three Drug User Fee Programs
January 24, 2012
Novartis Issues Recall and Suspends Operations at US Facility
January 17, 2012
BMS to Acquire Inhibitex for $2.5 Billion
January 17, 2012
Budget Crunch, Political Battles Shape Policy Agenda for Year
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
BioPharm International - January 1, 2012
FDA Revamps to Meet New Challenges
Added responsibilities and outside concerns prompt overhaul of agency's structure.
BioPharm International - December 1, 2011
Drug Shortages Create Crisis for Manufacturers, Regulators
Clamor mounts over compromised care and rising costs due to lack of crucial therapies.
BioPharm International - November 1, 2011
Weekly Poll
What is the most important change that has influenced chemical API manufacturing during the past 10 years?
Advancements in chemocatalysis (for use in asymmetric hydrogenation and other asymmetric syntheses)
Adoption of biocatalysis in organic chemical synthesis
Development of microreactors for continuous manufacturing
Application of quality-by-design principles in process development and manufacturing
Advancements in chemocatalysis (for use in asymmetric hydrogenation and other asymmetric syntheses)
0%
Adoption of biocatalysis in organic chemical synthesis
17%
Development of microreactors for continuous manufacturing
0%
Application of quality-by-design principles in process development and manufacturing
83%
View Results
Mass Spectrometry Compatible Separation of Itraconazole Substances by UHPLC
December 27, 2011
Quality By Design in Biomanufacturing Bioproduction Group
December 27, 2011
Rapid Screening of Sialic Acids in Glycoproteins by HPAE-PAD
November 29, 2011
Ion Chromatography Services
November 29, 2011
Glycosylation of Proteins – Structure, Function & Analysis
November 29, 2011
Click here